Products

SLIM DATA USB This new product unveiled at the recent CES show in Las Vegas is a must have for any medical professional who carries data on a flash drive. This credit card size flash drive which you can carry in your wallet can hold 4 GB of information and …

 TrackitBack Have you ever lost a cell phone or a camera or your ipod? Have you ever received a call from a patient that their child has lost their insulin pump? Now there is a new service, introduced at the recent CES exhibition in Las Vegas that can find it …

Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure. Valturna combines in a single pill valsartan, an angiotensin receptor blocker, with aliskiren, the only approved direct renin inhibitor. Valturna is the first therapy to target two points within the renin angiotensin …

Pitavastatin (Livalo, Kowa Pharmaceuticals), a HMG-CoA reductase inhibitor, was approved as a primary treatment for hypercholesterolemia and combined dyslipidemia. This new medication has a unique cyclopropyl group on its base structure, giving it the potential for greater LDL clearance and the reduction of plasma cholesterol. The manufacturer also said that …

Diabetes in Control is the first to present the Solo product information to the diabetes community.   The FDA approved the Solo MicroPump for sale in the US on July 28th, The Solo MicroPump will be the smallest, lightest, most discreet full-featured insulin pump in the market. In addition, it will offer …

The US Food and Drug Administration has approved a new indication for a single-tablet combination of the renin inhibitor aliskiren (Tekturna® HCT) and the diuretic hydrochlorothiazide for the first-line treatment of hypertension in patients likely to require multiple medications to achieve their blood pressure goals. The combination tablet previously was …

FDA Approves ACTOplus met(R) XR Tablets for the Treatment of Type 2 Diabetes Another “not new” drug, but new combination added to the arsenal for treating diabetes. Takeda Pharmaceuticals North America, Inc., has announced that the FDA approved an extended-release version of the combination medication ACTOplus met(R) (pioglitazone HCl and …

FDA Approves A New First In Class Diabetes Drug – Cycloset™ People with Type 2 diabetes may soon get a very different treatment approach

Generex Biotechnology announced today the successful Phase III study data for their buccal oral insulin product, Oral-lyn™. The product’s non-inferiority to injectable meal-time (prandial) insulin appears to be real and repeatable. Update on Oral-lyn

Worst diet promotions of 2008 snag 20th Annual Slim Chance Awards- Each year the Healthy Weight Network evaluates all the fad diets and programs and selects the worst of the worst. Check out this years list.